Skip to content

Cortical mechanisms underlying effects of Repetitive Peripheral Magnetic Stimulation on Dynamic and Static Postural Control in patients with CNLBP

Cortical mechanisms underlying effects of Repetitive Peripheral Magnetic Stimulation on Dynamic and Static Postural Control in patients with CNLBP

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300070943
Enrollment
Unknown
Registered
2023-04-26
Start date
2023-05-02
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Low back pain

Interventions

rPMS:rPMS+core muscle training
sham-rPMS:sham-rPMS+core muscle training

Sponsors

The First Affiliated Hospital, Sun Yat-Sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1) Pain in the area below the T12 margin, above the transverse stria of the buttocks, and between the axillary midlines on both sides, with a duration of not less than 3 months, without numbness and radiative pain of the lower limbs; 2) Between 18-55 years of age; 3) No pacemaker or implanted stent in the body; 4) Signing informed consent for study participation.

Exclusion criteria

Exclusion criteria: 1) Specific low back pain or other chronic pathological pain caused by cancer/tumor, tuberculosis, fracture, infection, and inflammatory diseases; 2) Associated with sciatica or root pain syndrome (eg, positive sign in the Lasègue test, abnormal knee-jerk reflex, and Achilles tendon reflex, sensory disturbance, muscle strength decline); 3) Definite orthopedic disease (eg, spinal trauma, severe osteoporosis, related surgical history); 4) Complicated with serious circulatory, respiratory, neurological or cardiac diseases; 5) Previous history of epilepsy, craniocerebral injury, cerebrovascular disease, and craniocerebral surgery; 6) Pregnant and lactating women; 7) Obesity with Body Mass Index (BMI) > 30; 8) Under other analgesic medication or treatment, or training targeted the core muscle in the last 3 months; 9) Having undergone any medications that affect the postural control ability, muscle strength and cortical excitability in the last 2 weeks.

Design outcomes

Primary

MeasureTime frame
Visual analog scale, VAS;Oswestry disability index, ODI;The short form-36 health survey, SF-36;

Secondary

MeasureTime frame
Muscle thickness and cross-sectional area of transverse abdominal muscle and multifidus muscle;Dynamic and static balancing ability (displacement area of pressure center and swing speed);Core muscle group muscle activation mode (muscle activation onset time);Changes in cortical activation (average ? HbO2 and ? HHb concentration, brain area activation localization, functional connectivity);

Countries

China

Contacts

Public ContactWang Chuhuai

The First Affiliated Hospital, Sun Yat-Sen University

yanty3@mail2.sysu.edu.cn+86 15626168487

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026